|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 96.31 USD | -0.78% |
|
-4.30% | +21.93% |
| 08-20 | Mirum Pharmaceuticals Insider Sold Shares Worth $4,000,000, According to a Recent SEC Filing | MT |
| 08-19 | US FDA approves Regeneron's rare bone disorder drug | RE |
| Market Cap | 6.25B 5.36B 5.01B 4.59B 8.61B 598B 8.72B 59.22B 23.09B 301B 23.48B 22.97B 994B | P/E 2026 * |
-6.37x | P/E 2027 * | -120x |
|---|---|---|---|---|---|
| Enterprise Value | 6.43B 5.51B 5.16B 4.72B 8.86B 616B 8.98B 60.93B 23.76B 309B 24.16B 23.64B 1,023B | EV / Sales 2026 * |
9.24x | EV / Sales 2027 * | 7.76x |
| Free-Float |
98.34% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Mirum Pharmaceuticals, Inc.
| 1 day | -0.78% | ||
| 1 week | -4.30% | ||
| Current month | -9.10% | ||
| 1 month | -15.78% | ||
| 3 months | -2.34% | ||
| 6 months | -9.05% | ||
| Current year | +21.93% |
| 1 week | 95.24 |  | 104.66 |
| 1 month | 88.88 | | 116.39 |
| Current year | 73.82 | | 130 |
| 1 year | 63.23 | | 130 |
| 3 years | 23.14 | | 130 |
| 5 years | 12.82 | | 130 |
| 10 years | 6.51 | | 130 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 47 | 2019-03-20 | |
Eric Bjerkholt
DFI | Director of Finance/CFO | 66 | 2023-09-10 |
Peter Radovich
PSD | President | 48 | 2024-01-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Grey
CHM | Chairman | 73 | 2019-03-20 |
Patrick Heron
BRD | Director/Board Member | 55 | 2018-11-06 |
| Director/Board Member | 47 | 2018-10-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/18/26 | Fiscal year | Controller/Auditor | 120,000 | 0.1968% | ||
| 8/11/26 | Sell | Chief Financial Officer | -6,001 | 0.0098% | ||
| 8/10/26 | Fiscal year | Founder | 60,000 | 0.0984% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.78% | -4.30% | +34.66% | +267.60% | 6.25B | |
| +0.88% | +6.38% | +76.40% | +126.87% | 1,119B | |
| +1.07% | +3.80% | +50.73% | +64.25% | 651B | |
| +1.20% | +6.21% | +25.81% | +80.15% | 468B | |
| -1.26% | +4.16% | +42.71% | +42.57% | 374B | |
| -0.67% | +2.79% | +25.29% | +41.15% | 302B | |
| -1.12% | +4.78% | +2.02% | +12.67% | 259B | |
| +1.29% | +5.81% | +49.57% | +70.71% | 238B | |
| +0.24% | +3.11% | -17.91% | -53.31% | 208B | |
| +1.87% | +5.61% | +27.32% | +89.67% | 181B | |
| Average | +0.27% | +4.22% | +31.66% | +74.23% | 380.61B | |
| Weighted average by Cap. | +0.52% | +5.38% | +44.13% | +72.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 697M 597M 558M 511M 959M 66.65B 972M 6.6B 2.57B 33.48B 2.62B 2.56B 111B | 816M 699M 654M 599M 1.12B 78.07B 1.14B 7.73B 3.01B 39.22B 3.06B 3B 130B |
| Net income | -933M -799M -748M -685M -1.28B -89.27B -1.3B -8.84B -3.45B -44.85B -3.5B -3.43B -148B | -32.99M -28.26M -26.44M -24.21M -45.43M -3.16B -46.03M -312M -122M -1.59B -124M -121M -5.24B |
| Net Debt | 181M 155M 145M 133M 249M 17.31B 252M 1.71B 668M 8.7B 679M 665M 28.76B | 74.95M 64.21M 60.08M 54.99M 103M 7.17B 105M 710M 277M 3.6B 281M 275M 11.92B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | US$96.31 | -0.78% | 731,683 |
| 26-08-20 | US$97.07 | -5.06% | 352,679 |
| 26-08-19 | US$102.24 | +1.36% | 556,271 |
| 26-08-18 | US$100.87 | +1.04% | 518,109 |
| 26-08-17 | US$99.83 | -0.80% | 407,631 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MIRM Stock
Select your edition
All financial news and data tailored to specific country editions
